Basilea Says Phase II Derazantinib Data Keep Drug’s Prospects On Track

Internal organs
Derazantinib Is In Phase II Testing For Intrahepatic Bile Duct Cancer • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Clinical Trials

More from R&D